Single-arm phase II study of low-dose paclitaxel and pembrolizumab in platinum-refractory metastatic urothelial carcinoma (UC).

被引：2
|
作者：
Bitting, Rhonda L. [1 ]
Vile, Donald Charles [2 ]
Tooze, Janet A. [3 ]
Thomas, Christopher Y. [1 ]
Neve, Morgan [1 ]
Kooshki, Mitra [1 ]
Brown, Jessica [4 ]
Dubey, Purnima [4 ]
Triozzi, Pierre [1 ]
Goodman, Michael Moses [1 ]
机构：
[1] Wake Forest Baptist Hlth, Ctr Comprehens Canc, Winston Salem, NC USA
[2] Wake Forest Baptist Hlth, Winston Salem, NC USA
[3] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA
[4] Ohio State Univ, Pelotonia Inst Immunooncol, James Comprehens Canc Ctr, Columbus, OH 43210 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 06期
关键词：
D O I：
10.1200/JCO.2021.39.6_suppl.433
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
433
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Phase II study of sunitinib in patients (pts) with relapsed or refractory urothelial carcinoma (UC)
    Gallagher, D. J.
    Milowsky, M. I.
    Gerst, S. R.
    Iasonos, A.
    Riches, J.
    Boyle, M. G.
    Bajorin, D. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [32] Phase Ib study of avelumab and taxane based chemotherapy in platinum-refractory or ineligible metastatic urothelial cancer (AVETAX study).
    Garje, Rohan
    Packiam, Vignesh T.
    Koski, Amy
    Milhem, Mohammed M.
    O'Donnell, Michael A.
    Zakharia, Yousef
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [33] Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study
    Giaccone, Giuseppe
    Kim, Chul
    Thompson, Jillian
    McGuire, Colleen
    Kallakury, Bhaskar
    Chahine, Joeffrey J.
    Manning, Maria
    Mogg, Robin
    Blumenschein, Wendy M.
    Tan, Ming T.
    Subramaniam, Deepa S.
    Liu, Stephen V.
    Kaplan, Ian M.
    McCutcheon, Justine N.
    LANCET ONCOLOGY, 2018, 19 (03): : 347 - 355
  • [34] Neoadjuvant pembrolizumab/nab-paclitaxel/cisplatin in patients with locally advanced head and neck squamous cell carcinoma: A single-arm phase II study
    Zhang, Siyi
    Ma, Haiqing
    Zhan, Jiandong
    Zhu, Lijun
    Zhang, Hong-Dan
    Du, Shasha
    Dong, Qiumei
    Wang, Guangyi
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [35] Pembrolizumab Monotherapy for Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Arm Phase II Trial (KEYNOTE-629)
    Grob, Jean-Jacques
    Gonzalez, Rene
    Basset-Seguin, Nicole
    Vornicova, Olga
    Schachter, Jacob
    Joshi, Abhishek
    Meyer, Nicolas
    Grange, Florent
    Piulats, Josep M.
    Bauman, Jessica R.
    Zhang, Pingye
    Gumuscu, Burak
    Swaby, Ramona F.
    Hughes, Brett G. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (25) : 2916 - +
  • [36] Anlotinib in patients with recurrent platinum-resistant or -refractory ovarian carcinoma: A prospective, single-arm, single-center, phase II clinical study
    Wang, H.
    Shan, B.
    Shen, W.
    ANNALS OF ONCOLOGY, 2021, 32 : S733 - S733
  • [37] Atezolizumab for Cisplatin-Inappropriate Patients with advanced or metastatic Urothelial Carcinoma Results of single-arm Phase-II-Study (IMvigor 210)
    Wezel, Felix
    Bolenz, Christian
    ONKOLOGE, 2017, 23 (10): : 858 - 860
  • [38] Elotuzumab in combination with thalidomide and low-dose dexamethasone: a phase 2 single-arm safety study in patients with relapsed/refractory multiple myeloma
    Mateos, Maria-Victoria
    Granell, Miguel
    Oriol, Albert
    Martinez-Lopez, Joaquin
    Blade, Joan
    Hernandez, Miguel T.
    Martin, Jesus
    Gironella, Mercedes
    Lynch, Mark
    Bleickardt, Eric
    Paliwal, Prashni
    Singhal, Anil
    San-Miguel, Jesus
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 175 (03) : 448 - 456
  • [39] Atezolizumab plus Magrolimab, Niraparib, or Tocilizumab versus Atezolizumab Monotherapy in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study (MORPHEUS Urothelial Carcinoma)
    Drakaki, Alexandra
    Powles, Thomas
    Bamias, Aristotelis
    Martin-Liberal, Juan
    Shin, Sang Joon
    Friedlander, Terence
    Tosi, Diego
    Park, Chandler
    Gomez-Roca, Carlos
    Lobbedez, Florence Joly
    Castellano, Daniel
    Morales-Barrera, Rafael
    Moreno-Candilejo, Irene
    Flechon, Aude
    Yuen, Kobe
    Rishipathak, Deepali
    Dupree, Kelly
    Young, Fiona
    Michielin, Francesca
    Shemesh, Colby S.
    Steinberg, Elizabeth E.
    Williams, Patrick
    Lee, Jae Lyun
    CLINICAL CANCER RESEARCH, 2023, 29 (21) : 4373 - 4384
  • [40] Low Dose Decitabine Combined with Taxol and Platinum Chemotherapy to Treat Refractory/Recurrent Ovarian Cancer: An Open-Label, Single-Arm, Phase I/II Study
    Fu, Xiaoyu
    Zhang, Yan
    Wang, Xiaohui
    Chen, Meixia
    Wang, Yao
    Nie, Jing
    Meng, Yuanguang
    Han, Weidong
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2015, 16 (04) : 329 - 336
12345